Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Zambon Group SpA

    EVENTS

    • Webinars & Exhibitions

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Zambon Switzerland Ltd.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    SCOPE Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SCOPE Summit
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2024-12-12

    Zambon Switzerland

    City : Cadempino

    State :

    Country/Area : Switzerland

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2024-12-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    SCOPE Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SCOPE Summit
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2019-12-13

    Zambon Switzerland

    City : Cadempino

    State :

    Country/Area : Switzerland

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2019-12-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    SCOPE Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SCOPE Summit
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2018-02-13

    Zambon Switzerland

    City : Cadempino

    State :

    Country/Area : Switzerland

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2018-02-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    SCOPE Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SCOPE Summit
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-03-30

    Zambon Switzerland

    City : Cadempino

    State :

    Country/Area : Switzerland

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-03-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    SCOPE Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SCOPE Summit
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-12-19

    Zambon Switzerland

    City : Cadempino

    State :

    Country/Area : Switzerland

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-12-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    SCOPE Summit
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SCOPE Summit
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2010-07-07

    Zambon Switzerland

    City : Cadempino

    State :

    Country/Area : Switzerland

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-07-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Zambon Group Spa and get a quotation

    Zambon Group Spa is a supplier offers 7 products (APIs, Excipients or Intermediates).

    Find a price of Diflunisal bulk offered by Zambon Group Spa

    Find a price of Flurbiprofen bulk offered by Zambon Group Spa

    Find a price of Iopamidol bulk offered by Zambon Group Spa

    Find a price of Naproxen bulk offered by Zambon Group Spa

    Find a price of Oxaprozin bulk offered by Zambon Group Spa

    Find a price of Tasosartan bulk offered by Zambon Group Spa

    Find a price of WAY-125,147 CRUDE bulk offered by Zambon Group Spa

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.